ProCE Banner Activity

Immune Checkpoint Inhibition in Early-Stage TNBC

Slideset Download
Downloadable slideset describing neoadjuvant and adjuvant immunotherapy in high-risk, early-stage triple-negative breast cancer.

Released: September 15, 2022

Expiration: September 14, 2023

No longer available for credit.

Share

Faculty

Denise A. Yardley

Denise A. Yardley, MD

Senior Investigator
Breast Cancer Research Program
The Sarah Cannon Research Institute and Tennessee Oncology
Nashville, Tennessee

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Lilly

Merck Sharp & Dohme Corp.

Partners

Smart Patients

ProCE Banner

Program Director Disclosure

Program Director

Denise A. Yardley, MD

Senior Investigator
Breast Cancer Research Program
The Sarah Cannon Research Institute and Tennessee Oncology
Nashville, Tennessee